Liang Lu
34Patents
18h-index
35Co-inventors
77Inventor score
Filing activity: Jun 12, 2013 → Apr 5, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9611267B2 | Substituted tricyclic compounds as FGFR inhibitors | Chemistry; Metallurgy | 40 | Active |
| US9388185B2 | Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors | Chemistry; Metallurgy | 40 | Active |
| US9745311B2 | Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors | Chemistry; Metallurgy | 40 | Active |
| US9708318B2 | Bicyclic heterocycles as FGFR4 inhibitors | Chemistry; Metallurgy | 39 | Active |
| US9533984B2 | Bicyclic heterocycles as FGFR inhibitors | Human Necessities | 38 | Active |
| US9580423B2 | Bicyclic heterocycles as FGFR4 inhibitors | Chemistry; Metallurgy | 38 | Active |
| US9801889B2 | Bicyclic heterocycles as FGFR4 inhibitors | Chemistry; Metallurgy | 36 | Active |
| US9890156B2 | Bicyclic heterocycles as FGFR4 inhibitors | Chemistry; Metallurgy | 34 | Active |
| US10040790B2 | Bicyclic heterocycles as FGFR inhibitors | Human Necessities | 32 | Active |
| US10214528B2 | Bicyclic heterocycles as FGFR4 inhibitors | Chemistry; Metallurgy | 30 | Active |
| US10131667B2 | Substituted tricyclic compounds as FGFR inhibitors | Chemistry; Metallurgy | 30 | Active |
| US10450313B2 | Bicyclic heterocycles as FGFR inhibitors | Human Necessities | 28 | Active |
| US10806785B2 | Immunomodulator compounds and methods of use | Human Necessities | 28 | Active |
| US9695168B2 | Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as LSD1 inhibitors | Chemistry; Metallurgy | 26 | Active |
| US9695180B2 | Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors | Chemistry; Metallurgy | 24 | Active |
| US10738048B2 | Bicyclic heterocycles as FGFR4 inhibitors | Chemistry; Metallurgy | 24 | Active |
| US10851105B2 | Bicyclic heterocycles as FGFR4 inhibitors | Chemistry; Metallurgy | 23 | Active |
| US11053246B2 | Substituted tricyclic compounds as FGFR inhibitors | Chemistry; Metallurgy | 18 | Active |
| US11014923B2 | Bicyclic heterocycles as FGFR4 inhibitors | Chemistry; Metallurgy | 18 | Active |
| US10112950B2 | Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors | Chemistry; Metallurgy | 15 | Active |
| US11673883B2 | Heterocyclic compounds as immunomodulators | Chemistry; Metallurgy | 9 | Active |
| US10556908B2 | Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors | Chemistry; Metallurgy | 8 | Active |
| US10640503B2 | Imidazopyridines and imidazopyrazines as LSD1 inhibitors | Chemistry; Metallurgy | 7 | Active |
| US11530214B2 | Bicyclic heterocycles as FGFR inhibitors | Human Necessities | 4 | Active |
| US11667635B2 | Bicyclic heterocycles as FGFR4 inhibitors | Chemistry; Metallurgy | 4 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.